178 related articles for article (PubMed ID: 17918923)
1. From docking false-positive to active anti-HIV agent.
Barreiro G; Kim JT; Guimarães CR; Bailey CM; Domaoal RA; Wang L; Anderson KS; Jorgensen WL
J Med Chem; 2007 Nov; 50(22):5324-9. PubMed ID: 17918923
[TBL] [Abstract][Full Text] [Related]
2. Search for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB/SA scoring.
Barreiro G; Guimarães CR; Tubert-Brohman I; Lyons TM; Tirado-Rives J; Jorgensen WL
J Chem Inf Model; 2007; 47(6):2416-28. PubMed ID: 17949071
[TBL] [Abstract][Full Text] [Related]
3. Development of nonnucleoside HIV reverse transcriptase inhibitors.
Tucker TJ; Lumma WC; Culberson JC
Methods Enzymol; 1996; 275():440-72. PubMed ID: 9026654
[No Abstract] [Full Text] [Related]
4. Design, synthesis, and anti-HIV-1 activity of 1-aromatic methyl-substituted 3-(3,5-dimethylbenzyl)uracil and N-3,5-dimethylbenzyl-substituted urea derivatives.
Sakakibara N; Baba M; Okamoto M; Toyama M; Demizu Y; Misawa T; Kurihara M; Irie K; Kato Y; Maruyama T
Antivir Chem Chemother; 2015 Feb; 24(1):3-18. PubMed ID: 26149262
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of quinoxaline compounds as anti-HIV agents targeting reverse transcriptase enzyme.
Fabian L; Taverna Porro M; Gómez N; Salvatori M; Turk G; Estrin D; Moglioni A
Eur J Med Chem; 2020 Feb; 188():111987. PubMed ID: 31893549
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents.
Barreca ML; Balzarini J; Chimirri A; De Clercq E; De Luca L; Höltje HD; Höltje M; Monforte AM; Monforte P; Pannecouque C; Rao A; Zappalà M
J Med Chem; 2002 Nov; 45(24):5410-3. PubMed ID: 12431069
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and SAR of a novel pyrazinone series with non-nucleoside HIV-1 reverse transcriptase inhibitory activity.
Heeres J; de Jonge MR; Koymans LM; Daeyaert FF; Vinkers M; Van Aken KJ; Arnold E; Das K; Kilonda A; Hoornaert GJ; Compernolle F; Cegla M; Azzam RA; Andries K; de Béthune MP; Azijn H; Pauwels R; Lewi PJ; Janssen PA
J Med Chem; 2005 Mar; 48(6):1910-8. PubMed ID: 15771435
[TBL] [Abstract][Full Text] [Related]
8. Hierarchical database screenings for HIV-1 reverse transcriptase using a pharmacophore model, rigid docking, solvation docking, and MM-PB/SA.
Wang J; Kang X; Kuntz ID; Kollman PA
J Med Chem; 2005 Apr; 48(7):2432-44. PubMed ID: 15801834
[TBL] [Abstract][Full Text] [Related]
9. Anti-HIV activity of new substituted 1,3,4-oxadiazole derivatives and their acyclic nucleoside analogues.
El-Sayed WA; El-Essawy FA; Ali OM; Nasr BS; Abdalla MM; Abdel-Rahman AA
Z Naturforsch C J Biosci; 2009; 64(11-12):773-8. PubMed ID: 20158144
[TBL] [Abstract][Full Text] [Related]
10. Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2.
Freeman GA; Andrews Iii CW; Hopkins AL; Lowell GS; Schaller LT; Cowan JR; Gonzales SS; Koszalka GW; Hazen RJ; Boone LR; Ferris RG; Creech KL; Roberts GB; Short SA; Weaver K; Reynolds DJ; Milton J; Ren J; Stuart DI; Stammers DK; Chan JH
J Med Chem; 2004 Nov; 47(24):5923-36. PubMed ID: 15537347
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
Wu B; Kuhen K; Ngoc Nguyen T; Ellis D; Anaclerio B; He X; Yang K; Karanewsky D; Yin H; Wolff K; Bieza K; Caldwell J; He Y
Bioorg Med Chem Lett; 2006 Jul; 16(13):3430-3. PubMed ID: 16632349
[TBL] [Abstract][Full Text] [Related]
12. Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1.
Hopkins AL; Ren J; Milton J; Hazen RJ; Chan JH; Stuart DI; Stammers DK
J Med Chem; 2004 Nov; 47(24):5912-22. PubMed ID: 15537346
[TBL] [Abstract][Full Text] [Related]
13. Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT.
Barreca ML; Rao A; De Luca L; Zappalà M; Monforte AM; Maga G; Pannecouque C; Balzarini J; De Clercq E; Chimirri A; Monforte P
J Med Chem; 2005 May; 48(9):3433-7. PubMed ID: 15857150
[TBL] [Abstract][Full Text] [Related]
14. Application of Structure-based Methods to Analyze Resistance Mutations for Chemically Diverse Non-Nucleoside Reverse Transcriptase Inhibitors.
Tabassum T; Azeem SM; Muwonge AN; Frey KM
Curr HIV Res; 2020; 18(4):283-291. PubMed ID: 32493197
[TBL] [Abstract][Full Text] [Related]
15. Optimization of azoles as anti-human immunodeficiency virus agents guided by free-energy calculations.
Zeevaart JG; Wang L; Thakur VV; Leung CS; Tirado-Rives J; Bailey CM; Domaoal RA; Anderson KS; Jorgensen WL
J Am Chem Soc; 2008 Jul; 130(29):9492-9. PubMed ID: 18588301
[TBL] [Abstract][Full Text] [Related]
16. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
[TBL] [Abstract][Full Text] [Related]
17. Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1.
Chan JH; Freeman GA; Tidwell JH; Romines KR; Schaller LT; Cowan JR; Gonzales SS; Lowell GS; Andrews CW; Reynolds DJ; St Clair M; Hazen RJ; Ferris RG; Creech KL; Roberts GB; Short SA; Weaver K; Koszalka GW; Boone LR
J Med Chem; 2004 Feb; 47(5):1175-82. PubMed ID: 14971897
[TBL] [Abstract][Full Text] [Related]
18. From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compounds.
Venkatraj M; Ariën KK; Heeres J; Joossens J; Dirié B; Lyssens S; Michiels J; Cos P; Lewi PJ; Vanham G; Maes L; Van der Veken P; Augustyns K
Bioorg Med Chem; 2014 Oct; 22(19):5241-8. PubMed ID: 25199582
[TBL] [Abstract][Full Text] [Related]
19. Dihydro-alkylthio-benzyl-oxopyrimidines as inhibitors of reverse transcriptase: synthesis and rationalization of the biological data on both wild-type enzyme and relevant clinical mutants.
Mugnaini C; Alongi M; Togninelli A; Gevariya H; Brizzi A; Manetti F; Bernardini C; Angeli L; Tafi A; Bellucci L; Corelli F; Massa S; Maga G; Samuele A; Facchini M; Clotet-Codina I; Armand-Ugón M; Esté JA; Botta M
J Med Chem; 2007 Dec; 50(26):6580-95. PubMed ID: 18052319
[TBL] [Abstract][Full Text] [Related]
20. Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis.
Kirschberg TA; Balakrishnan M; Huang W; Hluhanich R; Kutty N; Liclican AC; McColl DJ; Squires NH; Lansdon EB
Bioorg Med Chem Lett; 2008 Feb; 18(3):1131-4. PubMed ID: 18083512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]